My research group has developed several research lines that all focus on a central theme, the discovery and development of novel therapeutic strategies targeting tumor cells. My long term research goal is the translation of laboratory finding to early clinical trials. After my Bachelor of Science in Biology at Sapienza University in 1999, Imoved to the field of cancer biology at the Regina Elena Cancer Institute (Rome) where my research has contributed to the understanding of consequences that modulation of anti-apoptotic member of bcl-2 family induces in human cancer. In particular during my PhD I found an important function for bcl-2 family proteins in angiogenesis. Then, I moved to Tumor Hypoxia Laboratory of the Developmental Therapeutics Program at the National Cancer Institute (NCI, Frederick, USA). Here, I investigated the molecular mechanism through which natural products induced apoptosis in cancer cells and the involvement of VEGF signaling in the survival of hypoxic cancer cells. In 2012, I started my own group studying mechanisms of epigenetic drugs induced tumor cell death, supported by a My first Grant AIRC. I have recently started my own research group at IBPM, focusing on the multifaceted role of lysine acetylation in cancer stem cells biology and tumor angiogenesis. |
. · Ferrara M, Sessa G, Fiore M, Bernard F, Asteriti IA, Cundari E, Colotti G, Ferla S, Desideri M, Buglioni S, Trisciuoglio D, Del Bufalo D, Brancale A, Degrassi F. Small molecules targeted to the microtubule-Hec1 interaction inhibit cancer cell growth through microtubule stabilization. Oncogene. 2017 Sep 18. doi:10.1038/onc.2017.320. · Fianco G, Mongiardi MP, Levi A, De Luca T, Desideri M, Trisciuoglio D, Del Bufalo D, Cinà I, Di Benedetto A, Mottolese M, Gentile A, Centonze D, Ferrè F, Barilà D. Caspase-8 contributes to angiogenesis and chemotherapy resistance in glioblastoma. Elife. 2017 Jun 8;6. pii: e22593. doi: 10.7554/eLife.22593. · Noto A, De Vitis C, Pisanu ME, Roscilli G, Ricci G, Catizone A, Sorrentino G, Chianese G, Taglialatela-Scafati O, Trisciuoglio D, Del Bufalo D, Di Martile M, Di Napoli A, Ruco L, Costantini S, Jakopin Z, Budillon A, Melino G, Del Sal G,Ciliberto G, Mancini R. Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ. Oncogene. 2017 Aug 10;36(32):4573-4584. doi: 10.1038/onc.2017.75. Epub 2017 Apr 3. Erratum in: Oncogene. 2017 Jun 19; · Palanisamy SK, Trisciuoglio D, Zwergel C, Del Bufalo D, Mai A. Metabolite profiling of ascidian Styela plicata using LC-MS with multivariate statistical analysis and their antitumor activity. J Enzyme Inhib Med Chem. 2017 Dec;32(1):614-623. doi: 10.1080/14756366.2016.1266344. · Garufi A, Trisciuoglio D, Cirone M, D'Orazi G. ZnCl2 sustains theadriamycin-induced cell death inhibited by high glucose. Cell Death Dis. 2016 Jun30;7(6):e2280. doi: 10.1038/cddis.2016.178. · Di Martile M, Del Bufalo D, Trisciuoglio D. The multifaceted role of lysineacetylation in cancer: prognostic biomarker and therapeutic target. Oncotarget 2016 Jun 14. doi: 10.18632/oncotarget.10048. Review. · Di Martile M, Desideri M, De Luca T, Gabellini C, Buglioni S, Eramo A, Sette G, Milella M, Rotili D, Mai A, Carradori S, Secci D, De Maria R, Del Bufalo D, Trisciuoglio D. Histone acetyltransferase inhibitor CPTH6 preferentially targets lung cancer stem-like cells. Oncotarget. 2016 Feb 8. doi: 10.18632/oncotarget.7238. · Trisciuoglio D, Desideri M, Farini V, De Luca T, Di Martile M, Tupone M G, Urbani A, D’Aguanno S, Del Bufalo D Affinity Purification-Mass Spectrometry analysis of bcl-2 interactome identified SLIRP as novel interacting protein.Cell Death &Disease 2016 Feb 11;7:e2090. doi: 10.1038/cddis.2015.357. . · Del Bufalo D, Desideri M, De Luca T, Di Martile M, Gabellini C, Monica V,Busso S, Eramo A, De Maria R, Milella M, Trisciuoglio D. Histone deacetylaseinhibition synergistically enhances pemetrexed cytotoxicity through induction of apoptosis and autophagy in non-small cell lung cancer. Mol Cancer. 2014 Oct9;13:230. doi: 10.1186/1476-4598-13-230. · Valente S, Trisciuoglio D, De Luca T, Nebbioso A, Labella D, Lenoci A Bigogno C, Dondio G, Miceli M, Brosch G, Del Bufalo D, Altucci L, Mai A.1,3,4-Oxadiazole-containing histone deacetylase inhibitors: anticancer activities in cancer cells. J Med Chem. 2014 Jul 24;57(14):6259-65. doi: 10.1021/jm500303u. |
Within IBPM:
• Dr Francesca Degrassi
• Dr Patrizia Filetici
With other institutions:
• Antonello Mai, Sapienza University of Rome, IT
• Donatella Del Bufalo, Regina Elena National Cancer Institute, Rome
• Rita Mancini, Sapienza University of Rome, IT
• Gabriella D’Orazi, University of Chieti
|
Personal Information
Date and place of birth: Rome, October 15, 1973
Work address: IBPM Institute of Molecular Biology and Pathology
CNR National Research Council of Italy
c/o Department of Biology and Biotechnology
Sapienza University
Via degli Apuli 4
00185 Rome, Italy
daniela.trisciuoglio@uniroma1.it
Education
• PhD in Physiology and Molecular Toxicology at the University of Siena, Italy, 2011.
• Board Certified-Specialist in Clinical Pathology at the University of L’Aquila”, Italy, 2005.
• Degree in Biological Science at the University of Rome “La Sapienza”, Italy, 1999.
Scientific and professional experiences
• Jannuary 2017-present: Researcher in staff at IBPM Institute of Molecular Biology and Pathology- CNR National Research Council of Italy.
• July 2016-December 2016: Research fellow at Regina Elena Cancer Institute, Rome Italy. Supervisor: Dr Donatella Del Bufalo.
• July 2015-June 2016: Recipient of 12-months research scholarship within the Grant “Post-Doctoral Fellowship-year 2015” funded by Fondazione Veronesi.
• Jannuary 2012-December 2014: Recipient of research fellow as Principal Investigator within the Grant from Italian Association for Cancer Research MFAG 2012-2014.
• September 2009-December 2011: Fellow as phD Student at the Laboratory of Experimental Chemotherapy, Regina Elena Cancer Institute, Rome Italy. Supervisor: Dr Donatella Del Bufalo.
• July 2007-July 2009: Fellow at the Laboratory of Experimental Chemotherapy, Regina Elena Cancer Institute. Supervisor: Dr Donatella Del Bufalo.
• March 2006-May 2007: Guest research at the Tumor Hypoxia Laboratory, National Cancer Institute Frederick. Supervisor: Dr Giovanni Melillo.
• Jannuary 2003-December 2005: Fellow at the Laboratory of Experimental Chemotherapy, Regina Elena Cancer Institute. Supervisor: Dr Gabriella Zupi.
• September 2000-December 2002: Research collaborator at the Laboratory of Experimental Chemotherapy, Regina Elena Cancer Institute, Rome Italy. Supervisor: Dr Gabriella Zupi.
• October 1997-July 1999: Attended as undergraduate student at the Comparative Toxicology Laboratory, Istituto Superiore di Sanità, Rome, Italy. Supervisor: Dr Orazio Sapora.
Awards and Honors
• 2015: Recipient of research scholarship within the Grant “Post-Doctoral Fellowship-year 2015” funded by Fondazione Veronesi.
• 2013: National Teaching Qualification to apply for a Faculty position as Associate Professor in Biochemistry (05/E1) at the Italian Universities
• 2013: National Teaching Qualification to apply for a Faculty position as Associate Professor in Molecular Biology (05/E2) at the Italian Universities
• 2010:EACR Meeting Bursary Awards.
• 2007:Trivella Awards at the Italian Society of Carcinogenesis Meeting.
|